Comparative Effectiveness and Safety of Oral P2Y12 Inhibitors in Patients on Chronic Dialysis

INTRODUCTION: Although oral P2Y(12) inhibitors (P2Y12-Is) are one of the most commonly prescribed medication classes in patients with end stage kidney disease on dialysis (ESKD), scarce data exist regarding their benefits and risks. METHODS: We compared effectiveness and safety of clopidogrel, prasu...

Descripción completa

Detalles Bibliográficos
Autores principales: Jain, Nishank, Phadnis, Milind A., Hunt, Suzanne L., Dai, Junqiang, Shireman, Theresa I., Davis, Clayton L., Mehta, Jawahar L., Rasu, Rafia S., Hedayati, S. Susan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418979/
https://www.ncbi.nlm.nih.gov/pubmed/34514199
http://dx.doi.org/10.1016/j.ekir.2021.06.031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418979/
https://www.ncbi.nlm.nih.gov/pubmed/34514199
http://dx.doi.org/10.1016/j.ekir.2021.06.031

Ejemplares similares